| P50 | author | Pavel Dulguerov | Q42653501 |
| P2093 | author name string | Bela S Purohit | |
| | Minerva Becker | |
| | Osman Ratib | |
| | Christoph D Becker | |
| | Angeliki Ailianou | |
| P2860 | cites work | Approaches for the optimization of MR protocols in clinical hybrid PET/MRI studies. | Q30570489 |
| | Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer | Q30884020 |
| | Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. | Q31108510 |
| | Imaging in head and neck squamous cell carcinoma: the potential role of PET/MRI. | Q33792289 |
| | Reduction of dental filling metallic artifacts in CT-based attenuation correction of PET data using weighted virtual sinograms optimized by a genetic algorithm | Q33814568 |
| | Parotid gland tumors: preliminary data for the value of FDG PET/CT diagnostic parameters | Q34135738 |
| | Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer | Q34380806 |
| | Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. | Q34961039 |
| | Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. | Q35797987 |
| | PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake | Q35889285 |
| | Normal variants in [18F]-fluorodeoxyglucose PET imaging | Q35920201 |
| | Role of 18FFDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls | Q36020380 |
| | Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders | Q36031432 |
| | Monitoring response to treatment in patients utilizing PET. | Q36031456 |
| | Quantitative diffusion-weighted magnetic resonance imaging in the evaluation of parotid gland masses: a study with histopathological correlation | Q86293680 |
| | Reply: To PMID 23789681 | Q87001996 |
| | Osteoradionecrosis after radiation therapy for head and neck cancer: differentiation from recurrent disease with CT and PET/CT imaging | Q87438918 |
| | Brown fat in breast cancer patients: analysis of serial (18)F-FDG PET/CT scans. | Q51811847 |
| | Recurrent thyroid cancer diagnosis: ROC study of the effect of a high-resolution head and neck 18F-FDG PET/CT scan. | Q53085947 |
| | Dedifferentiated laryngeal chondrosarcoma: combined morphologic and functional imaging with positron-emission tomography/magnetic resonance imaging. | Q53088988 |
| | A study on the artifacts generated by dental materials in PET/CT image. | Q53092711 |
| | Feasibility of simultaneous PET/MR imaging in the head and upper neck area. | Q53245190 |
| | Contrast-enhanced ¹⁸F-FDG-PET/CT for the assessment of necrotic lymph node metastases. | Q53283087 |
| | Clinical utility of 18F-FDG PET for patients with salivary gland malignancies. | Q53501431 |
| | Utility of 18F-FDG PET/CT uptake patterns in Waldeyer's ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx. | Q53505562 |
| | Hibernomas show intense accumulation of FDG positron emission tomography. | Q53541892 |
| | Teflon granuloma in the nasopharynx: a potentially false-positive PET/CT finding. | Q53594922 |
| | Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. | Q53600245 |
| | Superphysiologic FDG Uptake in the Non-Paralyzed Vocal Cord. Resolution of a False-Positive PET Result with Combined PET-CT Imaging | Q73871719 |
| | Atrophy of the posterior cricoarytenoid muscle as an indicator of recurrent laryngeal nerve palsy | Q77372238 |
| | Atlas of confounding factors in head and neck PET/CT imaging | Q83787270 |
| | Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck | Q84253524 |
| | Nonspecific FDG uptake in the tongue mimicking the primary tumor in a patient with cancer of unknown primary | Q84839809 |
| | Imaging of the salivary glands | Q85465493 |
| | Critical clinical appraisal of the role of ultrasound guided fine needle aspiration cytology in the management of parotid tumours | Q36159031 |
| | Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake | Q36190011 |
| | Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging | Q36190016 |
| | PET/MRI in head and neck cancer: initial experience. | Q36434808 |
| | Scalene muscle uptake: a potential pitfall in head and neck PET/CT. | Q36957569 |
| | Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence | Q36978641 |
| | Pathology of the trigeminal nerve | Q37158032 |
| | Pathologic conditions of the lower cranial nerves IX, X, XI, and XII. | Q37158043 |
| | PET monitoring of therapy response in head and neck squamous cell carcinoma | Q37452341 |
| | FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. | Q37469186 |
| | PET/CT in the assessment of previously treated skull base malignancies. | Q37523571 |
| | Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT. | Q37554929 |
| | Radiolucent lesions of the mandible: a pattern-based approach to diagnosis | Q37628910 |
| | Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake. | Q37736168 |
| | Diffusion-weighted MR imaging in the head and neck. | Q37995998 |
| | Unilateral vocal cord paralysis: a review of CT findings, mediastinal causes, and the course of the recurrent laryngeal nerves | Q38009811 |
| | Risk factors for osteoradionecrosis after head and neck radiation: a systematic review | Q38016306 |
| | Pitfalls in the staging of cancer of the major salivary gland neoplasms | Q38064024 |
| | Imaging of laryngeal trauma. | Q38163172 |
| | Ophthalmologic abnormalities on FDG-PET/CT: a pictorial essay | Q39262341 |
| | Prevalence and pattern of brown adipose tissue distribution of 18F-FDG in patients undergoing PET-CT in a subtropical climatic zone | Q39350304 |
| | (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients | Q39919495 |
| | How reliable is sonography in the assessment of sialolithiasis? | Q40119184 |
| | MR-driven metal artifact reduction in PET/CT. | Q42691272 |
| | Elevated F-18 FDG uptake in laryngeal muscles mimicking thyroid cancer metastases | Q43673090 |
| | Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants | Q43987733 |
| | Identification of inflamed atherosclerotic lesions in vivo using PET-CT. | Q44029089 |
| | Thyroid nodule mimicking cervical adenopathy on FDG positron emission tomographic imaging | Q44111866 |
| | Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examinat | Q44791637 |
| | The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease | Q45300713 |
| | Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging | Q46099937 |
| | Does reducing CT artifacts from dental implants influence the PET interpretation in PET/CT studies of oral cancer and head and neck cancer? | Q46541584 |
| | The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. | Q46698912 |
| | Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management | Q46720755 |
| | Long-term changes induced by high-dose irradiation of the head and neck region: imaging findings | Q48813318 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography | Q130273251 |
| P304 | page(s) | 585-602 | |
| P577 | publication date | 2014-08-26 | |
| P1433 | published in | Insights into imaging | Q27723943 |
| P1476 | title | FDG-PET/CT pitfalls in oncological head and neck imaging | |
| P478 | volume | 5 | |